Indaptus Therapeutics Chief Executive Office Jeffrey Meckler's 2023 pay falls 40% to $1M
Indaptus Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 26, 2024
Indaptus Therapeutics reported fiscal year 2023 executive compensation information on April 26, 2024.
In 2023, three executives at Indaptus Therapeutics received on average a compensation package of $830K, a 35% decrease compared to previous year.
Average pay of disclosed executives at Indaptus Therapeutics
Jeffrey A. Meckler, Chief Executive Office, received $1M in total, which decreased by 40% compared to 2022. 56% of Meckler's compensation, or $565K, was in salary. Meckler also received $223K in non-equity incentive plan, $134K in option awards, as well as $79K in other compensation.
Walt A. Linscott, Chief Operating Officer, received a compensation package of $770K, which decreased by 9% compared to previous year. 55% of the compensation package, or $425K, was in salary.
Michael J. Newman, Chief Scientific Officer, earned $718K in 2023.
Related executives
You may also like
Source: SEC filing on April 26, 2024.